Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

AK Schlag, J Aday, I Salam… - Journal of …, 2022 - journals.sagepub.com
Background: Despite an increasing body of research highlighting their efficacy to treat a
broad range of medical conditions, psychedelic drugs remain a controversial issue among …

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

FX Vollenweider, KH Preller - Nature Reviews Neuroscience, 2020 - nature.com
Renewed interest in the use of psychedelics in the treatment of psychiatric disorders
warrants a better understanding of the neurobiological mechanisms underlying the effects of …

[HTML][HTML] REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics

RL Carhart-Harris, KJ Friston - Pharmacological reviews, 2019 - ASPET
This paper formulates the action of psychedelics by integrating the free-energy principle and
entropic brain hypothesis. We call this formulation relaxed beliefs under psychedelics …

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies

KAA Andersen, R Carhart‐Harris… - Acta Psychiatrica …, 2021 - Wiley Online Library
Objective To conduct a systematic review of modern‐era (post‐millennium) clinical studies
assessing the therapeutic effects of serotonergic psychedelics drugs for mental health …

[HTML][HTML] Psychedelics promote structural and functional neural plasticity

C Ly, AC Greb, LP Cameron, JM Wong, EV Barragan… - Cell reports, 2018 - cell.com
Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology of
depression and related disorders. The ability to promote both structural and functional …

[HTML][HTML] Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker… - …, 2018 - Springer
Rationale Recent clinical trials are reporting marked improvements in mental health
outcomes with psychedelic drug-assisted psychotherapy. Objectives Here, we report on …

[HTML][HTML] Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

L Roseman, DJ Nutt, RL Carhart-Harris - Frontiers in pharmacology, 2018 - frontiersin.org
Introduction: It is a basic principle of the “psychedelic” treatment model that the quality of the
acute experience mediates long-term improvements in mental health. In the present paper …

Psychedelics and the essential importance of context

RL Carhart-Harris, L Roseman… - Journal of …, 2018 - journals.sagepub.com
Psychedelic drugs are making waves as modern trials support their therapeutic potential
and various media continue to pique public interest. In this opinion piece, we draw attention …

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis

K Ko, EI Kopra, AJ Cleare, JJ Rucker - Journal of Affective Disorders, 2023 - Elsevier
Background Psychedelic therapy shows promise for Major Depressive Disorder, especially
when treatment-resistant, as well as life-threatening illness distress. The objective of this …

Classical psychedelics for the treatment of depression and anxiety: A systematic review

S Muttoni, M Ardissino, C John - Journal of affective disorders, 2019 - Elsevier
Background Depression and anxiety are prevalent psychiatric disorders that carry significant
morbidity. Pharmacological and psychosocial interventions are used to manage these …